Amin A - Search Results

1

Target-specific oral anticoagulants and the hospitalist.

Deitelzweig S, Amin A. Deitelzweig S, et al. Among authors: amin a. Hosp Pract (1995). 2015;43(1):1-12. doi: 10.1080/21548331.2015.998157. Epub 2015 Jan 6. Hosp Pract (1995). 2015. PMID: 25559350 Review.

2

Contemporary NSTEMI management: the role of the hospitalist.

Pollack CV, Amin A, Wang T, Deitelzweig S, Cohen M, Slattery D, Fanikos J, DiLascia C, Tuder R, Kaatz S. Pollack CV, et al. Among authors: amin a. Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20. Hosp Pract (1995). 2020. PMID: 31815570 Review.

3

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US.

Amin A, Deitelzweig S, Bucior I, Lin J, Lingohr-Smith M, Menges B, Neuman WR. Amin A, et al. J Med Econ. 2019 Nov;22(11):1119-1125. doi: 10.1080/13696998.2019.1618862. Epub 2019 Jun 4. J Med Econ. 2019. PMID: 31084383 Free article.

4

A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: balancing the risks and benefits.

Amin A, Deitelzweig S. Amin A, et al. Thromb J. 2015 Aug 21;13:29. doi: 10.1186/s12959-015-0056-y. eCollection 2015. Thromb J. 2015. PMID: 26300695 Free PMC article.

5

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.

Deitelzweig S, Amin A, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Deitelzweig S, et al. Among authors: amin a. J Med Econ. 2012;15(4):776-85. doi: 10.3111/13696998.2012.680555. Epub 2012 Apr 13. J Med Econ. 2012. PMID: 22449118 Free article.

6

New options for anticoagulation following total hip arthroplasty and total knee arthroplasty: new oral agents on the horizon.

Amin A. Amin A. Hosp Pract (1995). 2012 Aug;40(3):19-26. doi: 10.3810/hp.2012.08.986. Hosp Pract (1995). 2012. PMID: 23086091 Review.

7

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks.

Deitelzweig S, Amin A, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Deitelzweig S, et al. Among authors: amin a. Cardiol Ther. 2013 Dec;2(2):165-70. doi: 10.1007/s40119-013-0020-5. Epub 2013 Aug 17. Cardiol Ther. 2013. PMID: 25135394 Free PMC article.

8

Role of hospitalists in the diagnosis of atrial fibrillation for the management of cryptogenic stroke patients.

Amin A. Amin A. Hosp Pract (1995). 2016 Dec;44(5):274-278. doi: 10.1080/21548331.2016.1258292. Epub 2016 Nov 17. Hosp Pract (1995). 2016. PMID: 27817241 Review.

9

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.

Amin A, Keshishian A, Dina O, Dhamane A, Nadkarni A, Carda E, Russ C, Rosenblatt L, Mardekian J, Yuce H, Baker CL. Amin A, et al. J Thromb Thrombolysis. 2019 Aug;48(2):240-249. doi: 10.1007/s11239-019-01838-5. J Thromb Thrombolysis. 2019. PMID: 30924051 Free PMC article.

10

Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.

Amin A, Bruno A, Trocio J, Lin J, Lingohr-Smith M. Amin A, et al. J Med Econ. 2015 Jun;18(6):399-409. doi: 10.3111/13696998.2015.1007210. Epub 2015 Feb 9. J Med Econ. 2015. PMID: 25586203 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,912 results

Search Page

Filters